Cargando…
Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo
FK506 (Tacrolimus) is a potent inhibitor of calcineurin that blocks IL2 production and is widely used to prevent transplant rejection and treat autoimmunity. FK506 treatment of dendritic cells (FKDC) limits their capacity to stimulate T cell responses. FK506 does not prevent DC survival, maturation,...
Autores principales: | Orange, Dana E, Blachere, Nathalie E, Fak, John, Parveen, Salina, Frank, Mayu O, Herre, Margo, Tian, Suyan, Monette, Sebastien, Darnell, Robert B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564474/ https://www.ncbi.nlm.nih.gov/pubmed/23390586 http://dx.doi.org/10.7554/eLife.00105 |
Ejemplares similares
-
Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer
por: Frank, Mayu O, et al.
Publicado: (2014) -
Inflammatory but not apoptotic death of granulocytes citrullinates fibrinogen
por: Blachère, Nathalie E., et al.
Publicado: (2015) -
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020) -
Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011) -
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992)